Cancidas 50 MG Injection

RxCUI: 828757
RxNorm name: Cancidas 50 MG Injection
Display name: Cancidas 50 MG Injection
Full name: Cancidas 50 MG Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CANCIDAS	CASPOFUNGIN ACETATE	Merck Sharp & Dohme LLC	3bad23a6-09a6-4194-9182-093ed61bc71c	2024-10-11	Warnings, Adverse reactions	Exact identifier rxcui: 828757

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3bad23a6-09a6-4194-9182-093ed61bc71c	Cancidas 50 MG Injection [PSN] · caspofungin acetate 50 MG Injection [Cancidas] [SBD] · Cancidas 50 MG (equivalent to caspofungin 54.6 MG) Injection [SY] · Cancidas 50 MG Injection [SY]	4	41	These highlights do not include all the information needed to use CANCIDAS safely and effectively. See full prescribing information for CANCIDAS. CANCIDAS® (caspofungin acetate) for injection, for intravenous use Initial U.S. Approval: 2001	20241011